Testosterone plus exercise to improve muscle strength and performance in men affected by inclusion body myositis (IBM)
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2019
Price : $35 *
At a glance
- Drugs Testosterone (Primary)
- Indications Inclusion body myositis
- Focus Therapeutic Use
- Acronyms TEX-IBM
- Sponsors Lawley Pharmaceuticals
- 30 Jul 2019 Planned End Date changed from 11 Jan 2019 to 31 Jul 2020.
- 30 Jul 2019 Status changed from not yet recruiting to active, no longer recruiting.
- 08 May 2018 New trial record